Cargando…

High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design

A high-quality NMR solution structure is presented for protein hMcl-1(171–327) which comprises residues 171–327 of the human anti-apoptotic protein Mcl-1 (hMcl-1). Since this construct contains the three Bcl-2 homology (BH) sequence motifs which participate in forming a binding site for inhibitors o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Gaohua, Poppe, Leszek, Aoki, Ken, Yamane, Harvey, Lewis, Jeffrey, Szyperski, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008586/
https://www.ncbi.nlm.nih.gov/pubmed/24789074
http://dx.doi.org/10.1371/journal.pone.0096521
_version_ 1782314482574295040
author Liu, Gaohua
Poppe, Leszek
Aoki, Ken
Yamane, Harvey
Lewis, Jeffrey
Szyperski, Thomas
author_facet Liu, Gaohua
Poppe, Leszek
Aoki, Ken
Yamane, Harvey
Lewis, Jeffrey
Szyperski, Thomas
author_sort Liu, Gaohua
collection PubMed
description A high-quality NMR solution structure is presented for protein hMcl-1(171–327) which comprises residues 171–327 of the human anti-apoptotic protein Mcl-1 (hMcl-1). Since this construct contains the three Bcl-2 homology (BH) sequence motifs which participate in forming a binding site for inhibitors of hMcl-1, it is deemed to be crucial for structure-based design of novel anti-cancer drugs blocking the Mcl1 related anti-apoptotic pathway. While the coordinates of an NMR solution structure for a corresponding construct of the mouse homologue (mMcl-1) are publicly available, our structure is the first atomic resolution structure reported for the ‘apo form’ of the human protein. Comparison of the two structures reveals that hMcl-1(171–327) exhibits a somewhat wider ligand/inhibitor binding groove as well as a different charge distribution within the BH3 binding groove. These findings strongly suggest that the availability of the human structure is of critical importance to support future design of cancer drugs.
format Online
Article
Text
id pubmed-4008586
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40085862014-05-09 High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design Liu, Gaohua Poppe, Leszek Aoki, Ken Yamane, Harvey Lewis, Jeffrey Szyperski, Thomas PLoS One Research Article A high-quality NMR solution structure is presented for protein hMcl-1(171–327) which comprises residues 171–327 of the human anti-apoptotic protein Mcl-1 (hMcl-1). Since this construct contains the three Bcl-2 homology (BH) sequence motifs which participate in forming a binding site for inhibitors of hMcl-1, it is deemed to be crucial for structure-based design of novel anti-cancer drugs blocking the Mcl1 related anti-apoptotic pathway. While the coordinates of an NMR solution structure for a corresponding construct of the mouse homologue (mMcl-1) are publicly available, our structure is the first atomic resolution structure reported for the ‘apo form’ of the human protein. Comparison of the two structures reveals that hMcl-1(171–327) exhibits a somewhat wider ligand/inhibitor binding groove as well as a different charge distribution within the BH3 binding groove. These findings strongly suggest that the availability of the human structure is of critical importance to support future design of cancer drugs. Public Library of Science 2014-05-02 /pmc/articles/PMC4008586/ /pubmed/24789074 http://dx.doi.org/10.1371/journal.pone.0096521 Text en © 2014 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Liu, Gaohua
Poppe, Leszek
Aoki, Ken
Yamane, Harvey
Lewis, Jeffrey
Szyperski, Thomas
High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design
title High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design
title_full High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design
title_fullStr High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design
title_full_unstemmed High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design
title_short High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design
title_sort high-quality nmr structure of human anti-apoptotic protein domain mcl-1(171-327) for cancer drug design
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008586/
https://www.ncbi.nlm.nih.gov/pubmed/24789074
http://dx.doi.org/10.1371/journal.pone.0096521
work_keys_str_mv AT liugaohua highqualitynmrstructureofhumanantiapoptoticproteindomainmcl1171327forcancerdrugdesign
AT poppeleszek highqualitynmrstructureofhumanantiapoptoticproteindomainmcl1171327forcancerdrugdesign
AT aokiken highqualitynmrstructureofhumanantiapoptoticproteindomainmcl1171327forcancerdrugdesign
AT yamaneharvey highqualitynmrstructureofhumanantiapoptoticproteindomainmcl1171327forcancerdrugdesign
AT lewisjeffrey highqualitynmrstructureofhumanantiapoptoticproteindomainmcl1171327forcancerdrugdesign
AT szyperskithomas highqualitynmrstructureofhumanantiapoptoticproteindomainmcl1171327forcancerdrugdesign